Latest Ask the Experts

Focal Therapy for Prostate Cancer: An Update

What are the major challenges regarding focal therapy for prostate cancer?

The New mCRPC Drugs

What have you learned about the differences in tolerability of the newer agents, adverse event profiles, and cost?

Latest Prostate Cancer News

Negative Confirmatory Biopsy a Good Sign in Prostate Cancer AS

Negative Confirmatory Biopsy a Good Sign in Prostate Cancer AS

Prostate cancer patients on active surveillance who have no cancer found on confirmatory biopsy have a reduced risk of grade and volume reclassification.

PSA Testing in Controls of Screening Trial May Undermine Results

PSA Testing in Controls of Screening Trial May Undermine Results

Over 15 years of follow-up, considerable proportion of men undergo prostate-specific antigen testing

Novel Markers May Predict Prostate Cancer in Non-Black Men

Novel Markers May Predict Prostate Cancer in Non-Black Men

No added benefit was seen with the addition of biomarkers for African-American men.

Multimodal Therapy Found to Benefit Men With LN-positive PCa

Multimodal Therapy Found to Benefit Men With LN-positive PCa

New findings suggest that clinicians consider the pathologic characteristics of the primary tumor as well as the burden of LN metastases when deciding on management, investigators say.

Post-RP Radiotherapy Benefits Selected Men With Elevated PSA

Post-RP Radiotherapy Benefits Selected Men With Elevated PSA

Radiotherapy for prostate cancer patients with persistently elevated PSA after radical surgery improved survival only among those with worse pathologic characteristics.

High-income US Counties Have Higher Diagnoses of PCa

High-income US Counties Have Higher Diagnoses of PCa

High-income counties had far higher diagnosis rates for the four cancers than low-income counties, but the combined mortality rate was similar for both.

Survival Up With Patient-Reported Symptom Monitoring During Chemo

Survival Up With Patient-Reported Symptom Monitoring During Chemo

The researchers found that the median overall survival was 31.2 and 26.0 months in the PRO and usual care groups, respectively.

Men Need Better Understanding of PCa Genetic Test Results

Men Need Better Understanding of PCa Genetic Test Results

Some men who undergo multigene testing for inherited prostate cancer misinterpret findings of variants of uncertain significance.

Surgery May Offer Better Survival for Younger Men With High-risk PCa

Surgery May Offer Better Survival for Younger Men With High-risk PCa

Younger patients who chose surgery vs radiation for initial treatment had a 48% survival advantage.

Extended PLND Not Associated With Short-Term Oncologic Benefits

Extended PLND Not Associated With Short-Term Oncologic Benefits

Extended pelvic lymph node dissection versus limited dissection during radical prostatectomy does not improve biochemical recurrence rates.

Chronic Prostatitis Has Adverse Effects on Sperm

Chronic Prostatitis Has Adverse Effects on Sperm

CBP was associated with a reduction in sperm concentration, sperm vitality, sperm total and progressive motility.

Single Radiation Dose Can Ease Spinal Cord Compression

Single Radiation Dose Can Ease Spinal Cord Compression

New findings establish single-dose radiotherapy as the standard of care for metastatic spinal canal compression, at least for patients with a short life expectancy, researcher says.

Survival Predictors ID'd in mCRPC Patients Treated With Sipuleucel-T

Survival Predictors ID'd in mCRPC Patients Treated With Sipuleucel-T

ECOG status and baseline PSA and PSADT are significantly associated with overall survival.

Low-PSA, High-Grade Prostate Cancer Especially Lethal

Low-PSA, High-Grade Prostate Cancer Especially Lethal

Men with PSA values of 2.5 ng/mL or less and Gleason 8 to 10 prostate tumors are at higher risk of death than other high-risk PCa patients.

Costs Rise After Discovery of Prostate Cancer Metastases

Costs Rise After Discovery of Prostate Cancer Metastases

The researchers found that predicted monthly costs remained relatively stable throughout the observation period among the controls.

Sign up for free e-Newsletters